Nature and Basis Statements of Conflict(s) of Interest for Voting Members of FDA Advisory Committee Members
The Agency is revising its procedures regarding the disclosure of conflicts of interest and waivers for voting advisory committee members in order to implement the requirements of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2006) (Nov. 10, 2005). This information is being provided as an interim measure to comply with the requirements of this law.
Meeting of the Nonprescription Drugs Advisory Committee
and Endocrinologic and Metabolic Drugs Advisory Committee
January 23, 2006
Neal Benowitz, M.D.
Terrence F. Blaschke, M.D.
Thomas Carpenter, M.D.
Marie Griffin, M.D.
Ruth M. Parker, M.D.
Nelson Watts, M.D. Not able to attend meeting
Margaret E. Wierman, M.D.
Alastair J. J. Wood, M.D.
January 18, 2006